Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults

Halobetasol propionate and tazarotene lotion 0.01%/0.045% (HP/TAZ) is a topical medication approved for the treatment of plaque psoriasis in adults. As a treatment modality, HP/TAZ has a combinatory therapeutic effect because it contains both a corticosteroid (HP) and a retinoid (TAZ) component. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Vidhatha, Myers, Bridget, Yang, Eric J, Bhutani, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295208/
https://www.ncbi.nlm.nih.gov/pubmed/32606876
http://dx.doi.org/10.2147/CCID.S252426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295208/
https://www.ncbi.nlm.nih.gov/pubmed/32606876
http://dx.doi.org/10.2147/CCID.S252426

Ejemplares similares